Physician profile
Vida Wong
NPI 1437532439
$2,556.33
in general payments reported to CMS, 2019-2025
22 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,576 · 2022: $391 · 2023: $408 · 2024: $57.74 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $408.89 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $375.36 | 2021-2023 | Jardiance |
| Teva Pharmaceuticals USA, INC. | $349.10 | 2021-2023 | Uzedy |
| Novo Nordisk INC | $334.31 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $301.70 | 2021-2022 | |
| Lilly USA, LLC | $213.46 | 2021-2024 | Mounjaro |
| Sanofi-Aventis U.S. LLC | $92.04 | 2021 | |
| Exact Sciences Corporation | $62.54 | 2023 | Cologuard Collection Kit |
| Abbvie INC. | $55.75 | 2025 | |
| Amgen INC. | $48.89 | 2021-2023 | Otezla, Repatha |
| Inspire Medical Systems, INC. | $45.88 | 2025 | Inspire |
| Pfizer INC. | $42.34 | 2021 | |
| Novartis Pharmaceuticals Corporation | $36.63 | 2021 | |
| Horizon Therapeutics Plc | $29.39 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $26.40 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $26.10 | 2022 | |
| Merck Sharp & Dohme LLC | $23.25 | 2021 | |
| Phathom Pharmaceuticals, INC. | $21.26 | 2024 | Voquezna |
| Avanir Pharmaceuticals, INC. | $20.70 | 2022 | |
| Althera Pharmaceuticals LLC | $15.15 | 2021 | |
| Esperion Therapeutics, INC. | $14.70 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vida Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.